Thomas Willnow
Chemistry
Max Delbruck Center for Molecular Medicine in the Helmholtz Association
Germany
Biography
Dr. Thomas Willnow is currently working as a scientist in the Department of Chemistry, Max Delbruck Center for Molecular Medicine in the Helmholtz Association , Germany. His research interests includes endogenous receptor. gene inactivation, transgenic overexpression. He is serving as an editorial member and reviewer of several international reputed journals. Dr. Thomas Willnow is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to endogenous receptor. gene inactivation, transgenic overexpression.
Research Interest
endogenous receptor. gene inactivation, transgenic overexpression.
Publications
-
Kjolby, M., Andersen, OM, Breiderhoff, T., Fjorback, AW, Pedersen, KM, Madsen, Jansen, , Sort1, encoded by the cardiovascular risk locus 1p13.3, is a novel regulator of hepatic lipoprotein export. Cell Metab. 12, 213-223
-
Christ, A., Christa, A., Kur, E., Lioubinski, O., Bachmann, S., * Willnow, TE, * Hammes, A. (2011). LRP2 is an auxiliary SHH receptor required to condition the forebrain ventral midline for inductive signals. Dev. Cell 22, 268-278
-
In the following, we present the results of the study of the results of the study by Schmidt, V., Baum, K., Lao, A., Rateitschak, K., Schmitz, Y., Teichmann, A., Wiesner, B., Petersen, CM, Nykjaer, A., Wolf, J., Wolkenhauerr , O., Willnow, TE (2012). Quantitative modeling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease. EMBO J. 31, 187-200
